Pursuant to NASD Rule 2711(h)(6) and NYSE Rule 472(k)(i)(h), please click on the ticker for the latest pricing chart available for the subject company that depicts price target and rating revisions.

The information provided herein and via the BlueMatrix weblink shall not be deemed an offer or solicitation on our part with respect to the sale or purchase of any securities. Additionally, the limited information provided herein and via the BlueMatrix weblink is not sufficient and shall not be construed as sufficient information upon which a reasonable investor could make an investment decision. Broadpoint Capital research is intended for Institutional Investors. Research reports are available through your Broadpoint Capital Registered Representative. Should you have any specific investment questions, please contact your Broadpoint Capital Registered Representative.

Sector Industry Analyst
Technology Advanced Materials Avinash Kant, Ph.D.
Healthcare Biotechnology Simos Simeonidis, Ph.D.
Healthcare Biotechnology David Webber
Energy Clean Technology Colin Rusch
Energy Cleantech / Biofuels Ronald A. Oster
Technology Enterprise Software Bradley G. Whitt
Energy Exploration and Production Thomas Covington
Healthcare Global Specialty Pharmaceuticals David Lickrish, CFA
Healthcare Healthcare Services Glenn Garmont
Technology Semiconductor Capital Equipment and Semiconductor Companies Gavin Duffy

<< Back to Research Overview

Transparency of Analysts' Performance
Broadpoint's rating system.
Learn More

© 2007 Broadpoint
Home  |  Contact Us  |  Disclosures  |  Privacy Policy  |  Careers